Skip to main content
. 2020 Nov 25;1(1):ltaa003. doi: 10.1093/immadv/ltaa003

Figure 1.

Figure 1.

Abatacept treatment affects circulating Tfh cell frequency and their phenotype. Circulating CXCR5-expressing CD4 T cells (here called Tfh) can express PD-1, ICOS or both (left). Following abatacept treatment the frequency of circulating Tfh cells is reduced and the Tfh cells that remain show markedly lower expression of ICOS and, to a lesser extent, PD-1 (right).